ATE116859T1 - Blutdrucksenkendes präparat. - Google Patents

Blutdrucksenkendes präparat.

Info

Publication number: ATE116859T1
Authority: AT; Austria
Prior art keywords: blood pressure; polymeric substance; lowering; vitamin; lowering preparation
Prior art date: 1990-07-04

Application number

AT90850263T

Other languages

English (en)

Inventor

Marcin Krotkiewski

Original Assignee

Marcin Krotkiewski

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-07-04

Filing date

1990-07-04

Publication date

1995-01-15

1990-07-04 Application filed by Marcin Krotkiewski filed Critical Marcin Krotkiewski

1995-01-15 Application granted granted Critical

1995-01-15 Publication of ATE116859T1 publication Critical patent/ATE116859T1/de

Links

239000008280 blood Substances 0.000 title 1
210000004369 blood Anatomy 0.000 title 1
239000000126 substance Substances 0.000 abstract 3
229930003316 Vitamin D Natural products 0.000 abstract 2
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 2
235000019166 vitamin D Nutrition 0.000 abstract 2
239000011710 vitamin D Substances 0.000 abstract 2
150000003710 vitamin D derivatives Chemical class 0.000 abstract 2
229940046008 vitamin d Drugs 0.000 abstract 2
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 abstract 1
241001474374 Blennius Species 0.000 abstract 1
206010020772 Hypertension Diseases 0.000 abstract 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
229940072056 alginate Drugs 0.000 abstract 1
229920000615 alginic acid Polymers 0.000 abstract 1
235000010443 alginic acid Nutrition 0.000 abstract 1
230000003276 anti-hypertensive effect Effects 0.000 abstract 1
230000036772 blood pressure Effects 0.000 abstract 1
230000000763 evoking effect Effects 0.000 abstract 1
239000000835 fiber Substances 0.000 abstract 1
150000004676 glycans Chemical class 0.000 abstract 1
229920001282 polysaccharide Polymers 0.000 abstract 1
239000005017 polysaccharide Substances 0.000 abstract 1
229910052708 sodium Inorganic materials 0.000 abstract 1
239000011734 sodium Substances 0.000 abstract 1
230000002195 synergetic effect Effects 0.000 abstract 1
150000003722 vitamin derivatives Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Natural Medicines & Medicinal Plants (AREA)
Biotechnology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Alternative & Traditional Medicine (AREA)
Molecular Biology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Cardiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

AT90850263T 1990-07-04 1990-07-04 Blutdrucksenkendes präparat. ATE116859T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP90850263A EP0464299B1 (de)	1990-07-04	1990-07-04	Blutdrucksenkendes Präparat

Publications (1)

Publication Number	Publication Date
ATE116859T1 true ATE116859T1 (de)	1995-01-15

Family

ID=8206056

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90850263T ATE116859T1 (de)	1990-07-04	1990-07-04	Blutdrucksenkendes präparat.

Country Status (6)

Country	Link
US (1)	US5141927A (de)
EP (1)	EP0464299B1 (de)
JP (1)	JP3048380B2 (de)
AT (1)	ATE116859T1 (de)
DE (1)	DE69016014T2 (de)
ES (1)	ES2070307T3 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5460957A (en) *	1992-04-28	1995-10-24	Maruha Corporation	Calcium alginate oligosaccharide and method for producing the same from potassium or sodium alginate
US5354743A (en) *	1992-09-15	1994-10-11	Thys Jacobs Susan	Method for the treatment of premenstrual syndrome with vitamin D
JP3331269B2 (ja) *	1994-12-02	2002-10-07	京三電機株式会社	止め弁の構造
US6462029B1 (en) *	1999-02-23	2002-10-08	Econugenics	Compositions and methods for treating mammals with modified alginates and modified pectins
TWI268138B (en)	2000-05-11	2006-12-11	Kanebo Seiyaku Ltd	Composition containing peptide and electrolyte excretion enhancing substance, and food containing the same
JP2002061765A (ja)	2000-06-08	2002-02-28	Toyoda Gosei Co Ltd	燃料遮断弁
JP2002154977A (ja) *	2000-09-05	2002-05-28	Kao Corp	飲食用組成物
WO2005011660A1 (en) *	2003-07-29	2005-02-10	Abbott Laboratories	Use of vitamin d to down regulate the renin-angiotensin-aldosterone system
CA2557999C (en) *	2004-03-30	2013-11-12	Ilypsa, Inc.	Methods and compositions for treatment of ion imbalances
US7429394B2 (en) *	2004-03-30	2008-09-30	Relypsa, Inc.	Ion binding compositions
KR101269766B1 (ko) *	2004-03-30	2013-05-30	리립사, 인크.	이온 결합 중합체 및 이의 용도
US7854924B2 (en) *	2004-03-30	2010-12-21	Relypsa, Inc.	Methods and compositions for treatment of ion imbalances
US8192758B2 (en) *	2004-03-30	2012-06-05	Relypsa, Inc.	Ion binding compositions
US8282960B2 (en) *	2004-03-30	2012-10-09	Relypsa, Inc.	Ion binding compositions
US7556799B2 (en) *	2004-03-30	2009-07-07	Relypsa, Inc.	Ion binding polymers and uses thereof
ES2344989T3 (es) *	2004-11-22	2010-09-13	Wisconsin Alumni Research Foundation	Analogos de 17,20(e)-deshidro vitamina d y sus usos.
AU2006299449B2 (en)	2005-09-30	2013-07-04	Relypsa, Inc.	Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
JP2009510233A (ja) *	2005-09-30	2009-03-12	レリプサ，インコーポレイテッド	架橋シェルを有するコア−シェルコンポジットを製造する方法および該方法によって生じたコア−シェルコンポジット
US10716798B2 (en) *	2007-02-21	2020-07-21	The Regents Of The University Of Michigan	Compositions and methods for tranquilizing heart muscle
PL2167069T3 (pl)	2007-05-23	2012-04-30	Amcol International Corp	Krzemiany warstwowe oddziałujące z cholesterolem oraz sposoby zmniejszania hipercholesterolemii u ssaka
US20090060943A1 (en) *	2007-08-31	2009-03-05	O'mara Brendan Joseph	Syndrome X Composition and Method of Lowering Blood Pressure and Glycemic Index
EP3431094B1 (de) *	2008-08-22	2022-12-07	Vifor (International) Ltd.	Vernetzte kationenaustauschpolymere, zusammensetzungen und verwendung in der behandlung von hyperkaliämie
WO2010022380A2 (en)	2008-08-22	2010-02-25	Relypsa, Inc.	Linear polyol stabilized polyfluoroacrylate compositions
US20100104527A1 (en) *	2008-08-22	2010-04-29	Relypsa, Inc.	Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
CN104822383A (zh)	2012-10-08	2015-08-05	瑞立普萨公司	治疗高血压和高血钾症的钾结合剂
CN103083483B (zh) *	2013-01-30	2015-07-01	中国中医科学院中医临床基础医学研究所	一种治疗1、2级高血压病的中药组合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1070910B (de) *		1959-12-10	zugll	Verfahren zur Herstellung von Alginsäure hohen Reinheitsgrades
GB760030A (en) *	1952-12-05	1956-10-31	Henkel & Cie Gmbh	Process for the manufacture of dispersive, water-soluble alginates with high solubility speed
SU589956A1 (ru) *	1976-01-12	1978-01-30	Полярный Научно-Исследовательский И Проектный Институт Морского Рыбного Хозяйства И Океанографии Им. Н.М.Книповича	Способ очистки растворов от примесей
JPS60206801A (ja) *	1984-03-30	1985-10-18	Kimitsu Kagaku Kenkyusho:Kk	有機溶剤可溶性アルギン酸の製造方法
CA1272953A (en) *	1984-10-08	1990-08-21	Yuji Makino	Pharmaceutical composition for external use containing active-type vitamin d.sub.3
GB8431119D0 (en) *	1984-12-10	1985-01-16	Fujisawa Pharmaceutical Co	Anti-arteriosclerotic composition
US4804536A (en) *	1985-06-13	1989-02-14	Shimizu Kagaku Kabushiki Kaisha	Dietary fibres of seaweed having ion-exchange ability
FR2584410B1 (fr) *	1985-07-05	1987-11-27	Inst Nal Polytechnique	Procede d'obtention d'agar-agar a partir de jus d'extraction d'algues
FR2592383B1 (fr) *	1985-12-26	1990-01-19	Adeline Andre	Procede de preparation d'un film souple d'alginate de calcium
US4840894A (en) *	1986-03-04	1989-06-20	The Trustees Of Columbia University In The City Of New York	Method for detecting a marker for essential hypertension and diagnostic use thereof
JPH0764804B2 (ja) *	1986-04-25	1995-07-12	住友製薬株式会社	活性型ビタミンｄ３のフッ素誘導体
US4789664A (en) *	1986-12-19	1988-12-06	The Procter & Gamble Company	Food compositions with superior blood cholesterol lowering properties
US4797300A (en) *	1987-04-10	1989-01-10	The Procter & Gamble Company	Compositions containing novel solid, nondigestible, fat-like compounds
US4962092A (en) *	1987-05-06	1990-10-09	The Procter & Gamble Company	Compositions for treating duodenal ulcers
EP0296800B1 (de) *	1987-06-23	1991-10-16	Yamanouchi Pharmaceutical Co. Ltd.	Vitamin D3-Derivate
US4897388A (en) *	1988-12-20	1990-01-30	Geriatric Research Institute, Inc.	Method of treating Alzheimer's disease
US4983268A (en) *	1989-08-03	1991-01-08	Fmc Corporation	High gel strength low electroendosmosis agarose

1990
- 1990-07-04 DE DE69016014T patent/DE69016014T2/de not_active Expired - Fee Related
- 1990-07-04 ES ES90850263T patent/ES2070307T3/es not_active Expired - Lifetime
- 1990-07-04 AT AT90850263T patent/ATE116859T1/de not_active IP Right Cessation
- 1990-07-04 EP EP90850263A patent/EP0464299B1/de not_active Expired - Lifetime
- 1990-07-13 JP JP02186941A patent/JP3048380B2/ja not_active Expired - Fee Related
- 1990-07-26 US US07/558,777 patent/US5141927A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0464299B1 (de)	1995-01-11
DE69016014T2 (de)	1995-08-31
DE69016014D1 (de)	1995-02-23
EP0464299A1 (de)	1992-01-08
ES2070307T3 (es)	1995-06-01
JPH0474124A (ja)	1992-03-09
US5141927A (en)	1992-08-25
JP3048380B2 (ja)	2000-06-05

Legal Events

Date	Code	Title	Description
1995-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69016014D1 (de)	1995-02-23	Blutdrucksenkendes Präparat.
CO4290432A1 (es)	1996-04-17	Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
DE69724272D1 (de)	2003-09-25	Puderförmige zusammensetzung zur nasalen anwendung
DK68990A (da)	1990-05-17	Vandoploeselige derivater af hyaluronsyre
FI904494A7 (fi)	1991-03-13	Diagnoosi ja monistusmenetelmiä aluke-kohde-epäparin eliminoimiseksi alukkeen 3'-päässä
KR880003616A (ko)	1988-05-28	상처치료제
TR199701490A2 (xx)	1998-06-22	3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
DE69719931D1 (de)	2003-04-24	Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren
ES2058651T3 (es)	1994-11-01	Uso derivados de guanidina para la fabricacion de un medicamento con actividad antagonista de npy.
FI870589A0 (fi)	1987-02-12	Ny farmaceutisk sammansaettning och foerfarande foer framstaellning av den.
KR910000158A (ko)	1991-01-29	의약용 화합물 및 그것의 사용방법
DE58902712D1 (de)	1992-12-17	N-acetylglucosamin-zubereitungen zur buccalen anwendung.
KR900007424A (ko)	1990-06-01	세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
NO893135D0 (no)	1989-08-03	Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
DE3752096D1 (de)	1997-09-04	Familie von auf Xanthan basierenden Polysaccharidpolymeren, welche Nichtacetylierten und/oder Nichtpyruvylierten Gum beeinhalten
ATE149507T1 (de)	1997-03-15	Lösliche, nichttoxische derivate von basischen polyenmakroliden, ihre herstellung und verwendung
DK0436252T3 (da)	1993-12-27	Farmaceutisk præparat til oral administration i flydende form
SE8704979L (sv)	1988-06-16	Nya furanuronsyraderivat, forfarande for deras framstellning och deras anvendning
AU2979899A (en)	1999-09-20	Treatment of viral disease in swine
SE9003311L (sv)	1991-04-18	Anvaendning av glykoproteiner, utvunna fraan gram (-) bakterier, foer tillverkning av kosmetiska eller dermatologiska kompositioner och kompositioner omfattande dessa glykoproteiner
KR940008678A (ko)	1994-05-16	주사용 메스나 액제
BR9710206A (pt)	1999-08-10	Uso de um agente de interleucina-8 e formulação farmacéutica antiviral
KR890017363A (ko)	1989-12-15	스트로빌루린 유도체, 이들의 제법 및 용도
RU93032280A (ru)	1996-04-20	Способ кератопротезирования сосудистых истонченных бельм
BG60089B2 (bg)	1993-10-29	Състав за отстраняване или инактивиране на вредни съставки в кръвта у хора и животни